Dexamethasone/etoposide/rituximabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1951卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36899-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：122 / 122

相关论文

共 50 条

[1] Cytarabine/dexamethasone/rituximabLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 196 - 196
[2] Dexamethasone/immune globulin/rituximabLack of efficacy: case report
Reactions Weekly, 2022, 1899 (1) : 163 - 163
[3] Dexamethasone/Etoposide/Immune globulinLack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 136 - 136
[4] Dexamethasone/etoposide/tocilizumabLack-of-efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 192 - 192
[5] RituximabLack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 432 - 432
[6] RituximabLack of efficacy: case report
Reactions Weekly, 2023, 1975 (1) : 335 - 335
[7] RituximabLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 446 - 446
[8] RituximabLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 872 - 872
[9] RituximabLack of efficacy: case report
Reactions Weekly, 2023, 1957 (1) : 475 - 475
[10] RituximabLack of efficacy: case report
Reactions Weekly, 2022, 1887 (1) : 607 - 607

← 1 2 3 4 5 →